Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2024-04-04 2024-04-03
Drug Identification Number 02296446 02296446
Brand name SANDOZ OMEPRAZOLE SANDOZ OMEPRAZOLE
Common or Proper name OMEPRAZOLE OMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients OMEPRAZOLE OMEPRAZOLE
Strength(s) 20MG 20MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100GRC BO 100GRC BO
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2024-04-03 2024-04-03
Remaining supply date 2024-04-03 2024-04-03
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments